blockbuster type potential with life changing treatments. ACAD and CYTK both have made huge gains this year. I will say that CYTK actually did a 1 for 6 reverse split, but it did not harm them in the least. It did bring their share count down to a much smaller size. Not saying INO will or should do the same but it is a possibility.Regardless, INO, like ACAD and CYTK, has a very bright future.